GC1111

Clinical trials for GC1111 explained in plain language.

Never miss a new study

Get alerted when new GC1111 trials appear

Sign up with your email to follow new studies for GC1111, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hunterase extended trial shows promise for managing hunter syndrome

Disease control Completed

This study looked at the long-term safety and effectiveness of Hunterase (idursulfase beta) in 30 people with Hunter syndrome over about one year. Participants had either completed a previous phase 3 study or had used Hunterase for at least six months. The goal was to monitor sid…

Matched conditions: GC1111

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

GC1111

Get alerted when new GC1111 trials appear

Hunterase extended trial shows promise for managing hunter syndrome